Cargando…
Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?
Major depressive disorder (MDD) is a severe mental illness that affects 5–20% of the general population. Current antidepressant drugs exert only a partial clinical efficacy because approximately 30% of depressed patients failed to respond to these drugs and antidepressants produce remission only in...
Autores principales: | Guerrera, Claudia Savia, Furneri, Giovanna, Grasso, Margherita, Caruso, Giuseppe, Castellano, Sabrina, Drago, Filippo, Di Nuovo, Santo, Caraci, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218094/ https://www.ncbi.nlm.nih.gov/pubmed/32435223 http://dx.doi.org/10.3389/fpsyg.2020.00857 |
Ejemplares similares
-
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
por: Guerrera, Claudia Savia, et al.
Publicado: (2023) -
Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptoms
por: Platania, Giuseppe Alessio, et al.
Publicado: (2023) -
The Apathy Evaluation Scale (AES-C): Psychometric Properties and Invariance of Italian Version in Mild Cognitive Impairment and Alzheimer’s Disease
por: Furneri, Giovanna, et al.
Publicado: (2021) -
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020) -
Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment
por: Bosco, Paolo, et al.
Publicado: (2013)